Prince Pharmaceutical Co., Ltd. (TPEX:6935)

Prince Pharmaceutical Revenue

Prince Pharmaceutical had revenue of 616.64M TWD in the half year ending June 30, 2026, with 81.46% growth. This brings the company's total for the last twelve months to 1.22B, up 53.43% year-over-year. In the year 2025, Prince Pharmaceutical had annual revenue of 1.06B with 53.07% growth. That makes Prince Pharmaceutical the 29,902nd largest company in the world by revenue and 1,461st in Taiwan.

• Revenue (ttm): 1.22B
• Revenue Growth: +53.43%
• P/S Ratio: 0.84
• Revenue / Employee: 5.67M
• Employees: 216
• Market Cap: 1.03B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Health Food Products Department 879.09M 83.2%
• Western Medicine Section 177.12M 16.8%

By Geography

Chart

• Taiwan 999.59M 94.6%
• Japan 41.81M 4.0%
• Singapore 11.30M 1.1%
• Other Countries 3.51M 0.3%

Fiscal year ended Dec 31, 2025 See the full Prince Pharmaceutical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.06B	366.18M	53.07%
Dec 31, 2024	690.03M	-63.30M	-8.40%
Dec 31, 2023	753.33M	40.80M	5.73%
Dec 31, 2022	712.53M	271.45M	61.54%
Dec 31, 2021	441.08M	145.28M	49.12%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 16, 2026

Data Sources Report a data error